Abstract

Background18F–fluoro-deoxyglucose positron emission tomography with computed tomography (FDG PET/CT) has been employed to define radiotherapy targets using a threshold based on the standardised uptake value (SUV), and has been described for use in cervical cancer. The aim of this study was to evaluate the concordance between the metabolic tumour volume (MTV) measured on FDG PET/CT and the anatomical tumour volume (ATV) measured on T2-weighted magnetic resonance imaging (T2W-MRI); and compared with the functional tumour volume (FTV) measured on diffusion-weighted MRI (DW-MRI) in cervical cancer, taking the T2W-ATV as gold standard.MethodsConsecutive newly diagnosed cervical cancer patients who underwent FDG PET/CT and DW-MRI were retrospectively reviewed from June 2013 to July 2017.Volumes of interest was inserted to the focal hypermetabolic activity corresponding to the cervical tumour on FDG PET/CT with automated tumour contouring and manual adjustment, based on SUV 20%–80% thresholds of the maximum SUV (SUVmax) to define the MTV20–80, with intervals of 5%.Tumour areas were manually delineated on T2W-MRI and multiplied by slice thickness to calculate the ATV.FTV were derived by manually delineating tumour area on ADC map, multiplied by the slice thickness to determine the FTV(manual). Diffusion restricted areas was extracted from b0 and ADC map using K-means clustering to determine the FTV(semi-automated).The ATVs, FTVs and the MTVs at different thresholds were compared using the mean and correlated using Pearson’s product-moment correlation.ResultsTwenty-nine patients were evaluated (median age 52 years). Paired difference of mean between ATV and MTV was the closest and not statistically significant at MTV30 (−2.9cm3, −5.2%, p = 0.301). This was less than the differences between ATV and FTV(semi-automated) (25.0cm3, 45.1%, p < 0.001) and FTV(manual) (11.2cm3, 20.1%, p = 0.001). The correlation of MTV30 with ATV was excellent (r = 0.968, p < 0.001) and better than that of the FTVs.ConclusionsOur study demonstrated that MTV30 was the only parameter investigated with no statistically significant difference with ATV, had the least absolute difference from ATV, and showed excellent positive correlation with ATV, suggesting its superiority as a functional imaging modality when compared with DW-MRI and supporting its use as a surrogate for ATV for radiotherapy tumour contouring.

Highlights

  • 18F–fluoro-deoxyglucose positron emission tomography with computed tomography (FDG PET/CT) has been employed to define radiotherapy targets using a threshold based on the standardised uptake value (SUV), and has been described for use in cervical cancer

  • Our study demonstrated that MTV30 was the only parameter investigated with no statistically significant difference with anatomical tumour volume (ATV), had the least absolute difference from ATV, and showed excellent positive correlation with ATV, suggesting its superiority as a functional imaging modality when compared with diffusion-weighted magnetic resonance imaging (MRI) (DW-MRI) and supporting its use as a surrogate for ATV for radiotherapy tumour contouring

  • In the era of more sophisticated treatment options such as image-guided adaptive radiotherapy, functional imaging techniques such as diffusion-weighted MRI (DW-MRI) and 18F–fluorodeoxyglucose positron emission tomography integrated with computed tomography (FDG PET/CT) have been demonstrated to provide information for more precise definition of radiation target [5,6,7]

Read more

Summary

Introduction

18F–fluoro-deoxyglucose positron emission tomography with computed tomography (FDG PET/CT) has been employed to define radiotherapy targets using a threshold based on the standardised uptake value (SUV), and has been described for use in cervical cancer. In the era of more sophisticated treatment options such as image-guided adaptive radiotherapy, functional imaging techniques such as diffusion-weighted MRI (DW-MRI) and 18F–fluorodeoxyglucose positron emission tomography integrated with computed tomography (FDG PET/CT) have been demonstrated to provide information for more precise definition of radiation target [5,6,7]. The use of ADC for measuring target volumes with different tissue characteristics for dose prescription in image-guided adaptive brachytherapy [15] and various segmentation methods with DW-MRI [16] have been studied. Further investigation in its clinical application to radiotherapy treatment planning is warranted

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call